Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Amphiphilic phosphorus-containing crown macromolecular material as well as preparation and application thereof

A macromolecular and amphiphilic technology, applied in medical preparations containing active ingredients, organic active ingredients, medical preparations with non-active ingredients, etc., to achieve good water solubility and biocompatibility, low cost, and good development foreground effect

Active Publication Date: 2021-10-22
DONGHUA UNIV
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Retrieval of related literature and patents at home and abroad has not found that amphiphilic phosphorus-containing crown macromolecule micelles with surface-modified phosphate groups are used as nanocarriers to load chemotherapy drugs Combination therapy of DOX for tumor immunotherapy and chemotherapy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amphiphilic phosphorus-containing crown macromolecular material as well as preparation and application thereof
  • Amphiphilic phosphorus-containing crown macromolecular material as well as preparation and application thereof
  • Amphiphilic phosphorus-containing crown macromolecular material as well as preparation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0097] (1) Put hexachlorocyclotriphosphazene (2.26mmol, 786mg) and anhydrous cesium carbonate (13.56mmol, 4.418g) into a reaction flask containing anhydrous THF (40mL), ice bath, dropwise add 4- Hydroxybenzaldehyde (11.3 mmol, 1.38 g). Subsequently, the ice bath was removed, and the mixture was stirred overnight at room temperature. After the reaction, it was centrifuged and concentrated under reduced pressure to a transparent solution, followed by purification by silica gel column chromatography (pentane / ethyl acetate), and finally obtained a colorless oily AB with 76% yield. 5 .

[0098] (2) Dissolve 2,3-diphenylmaleic anhydride (4mmol, 1g) and tyramide (4mmol, 0.548g) in acetic acid, and add N,N-diisopropyl dropwise at 160°C-170°C Ethylamine (DAPIPEA) solution, reacted for 90 minutes. After the above substance was cooled to room temperature, 50 mL of distilled water was added and filtered to obtain a yellow precipitate. Purified by column chromatography (the mobile phas...

Embodiment 2

[0136] Prepare different concentrations of M-G1-TBPNa solutions (0.001mg / mL-2mg / mL), and add the prepared solutions to the solution containing the fluorescent probe pyrene (10μL, 4.0×10 -4 M) in the volumetric flask, the final concentration of pyrene is 6.0 × 10 -7 M, sonicate for 30 minutes, store overnight at room temperature. The fluorescence spectrophotometer measures the fluorescence spectrum with an excitation wavelength of 333nm, sets the incident slit width of the steady-state fluorometer to 1.0nm, and the receiving slit width to 1.2nm, and records the fluorescence curve of each solution in the range of 350-435nm. The lg value and I of M-G1-TBPNa concentration 373 / I 393 The fluorescence intensity ratio is analyzed on the horizontal and vertical coordinates, such as Figure 9 As shown, with the increase of M-G1-TBPNa concentration I 373 / I 393 The fluorescence intensity ratio of the first increase, followed by a significant decline at 208.5μM. This shows that the ...

Embodiment 3

[0138] Dissolve doxorubicin hydrochloride (DOX) in methanol, then add triethylamine (TEA) in an equimolar amount to doxorubicin hydrochloride, and ultrasonicate for 5 minutes to deprotonate doxorubicin hydrochloride into doxorubicin. According to different molar ratios (M-G1-TBPNa:DOX=1:0.5, 1:1, 1:2), add a certain amount of DOX methanol solution into the M-G1-TBPNa aqueous solution, and stir at room temperature overnight in the dark . Then move the mixed solution into a centrifuge tube, and centrifuge twice at 7000rpm for 20 minutes. After each centrifugation, take the supernatant, resuspend the precipitate with an appropriate amount of ultrapure water, and then perform the next centrifugation. Dissolve the precipitate in 1 mL of methanol, measure its UV absorbance at 480 nm, and calculate the encapsulation and uploading efficiencies of DOX by comparing with the standard curve of pure DOX. The results are shown in Table 1. When the feed ratio of M-G1-TBPNa and DOX was 1:0.5...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an amphipathic phosphorus-containing crown macromolecular material as well as preparation and application thereof. The structure of the amphipathic phosphorus-containing crown macromolecular material is represented by a formula I in the specification. The raw materials are commercialized, the preparation method is simple and easy to operate, and the prepared nano-composite can cause death of immunogenic tumor cells to increase the proportion of cytotoxic T cells on one hand, and can promote proliferation of natural killer cells in vivo on the other hand, so that the aims of remodeling a tumor microenvironment and enhancing anti-tumor immunotherapy are achieved, and good application prospects are realized in the field of tumor treatment.

Description

technical field [0001] The invention belongs to the field of functional nanometer materials and their preparation and application, in particular to an amphiphilic phosphorus-containing crown macromolecule material and its preparation and application. Background technique [0002] In recent years, immunotherapy has developed rapidly as a new therapeutic strategy. This treatment method aims to activate immune cells to recognize and eliminate tumor cells, so as to inhibit tumor progression and prevent tumor recurrence. Some chemotherapeutic drugs (such as paclitaxel, doxorubicin, or oxaliplatin) can induce immunogenic death (ICD) of tumor cells, releasing tumor antigens and risk-associated molecular patterns to activate antigens, both of which are detected by antigen-presenting cells (APCs). After capture, the antigen is processed and presented to adaptive immune cells to generate an antigen-specific immune response (Hu M. et al. Small, 2020, 16(50): 1613-6810). However, this...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C08G83/00A61K9/107A61K31/704A61K31/787A61K45/00A61K47/24A61P35/00A61P37/02
CPCC08G83/003A61K9/1075A61K45/00A61K31/704A61K47/24A61P35/00A61P37/02A61K31/787A61K2300/00
Inventor 史向阳詹梦偲范钰陈亮邱洁茹沈明武
Owner DONGHUA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com